ABOUT AMBRISENTAN

The first step in developing regenerative drugs strategies to take care of renal diseases applying pluripotent stem cells should be the generation of intermediate mesoderm (IM), an embryonic germ layer that gives rise to kidneys. In an effort to accomplish this objective, setting up an efficient, steady and small-Expense system for differentiating